Granules India’s Visakhapatnam Facility Received EU GMP Approval

Granules India Limited-Unit-V, high potent API and Finished Formulations manufacturing facility located at Visakhapatnam, Andhra Pradesh, India has received EU GMP approval. This approval is valid for three years.

This facility was audited in the month of January 2020 for good manufacturing practices of API and Oral solid dosage.

Shares of GRANULES INDIA LTD. was last trading in BSE at Rs.141.05 as compared to the previous close of Rs. 141.3. The total number of shares traded during the day was 113041 in over 3760 trades.

The stock hit an intraday high of Rs. 148 and intraday low of 138.05. The net turnover during the day was Rs. 16198879.-Equity Bulls

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.